Literature DB >> 20303493

Mutation of the protein kinase A phosphorylation site influences the anti-proliferative activity of mitofusin 2.

Wei Zhou1, Kuang-Hueih Chen, Wenjing Cao, Jingwei Zeng, Hua Liao, Li Zhao, Xiaomei Guo.   

Abstract

OBJECTIVE: Mitofusin 2 (Mfn2) is an important suppressor of vascular smooth muscle cell (VSMC) proliferation. It contains a protein kinase A (PKA) phosphorylation site at serine 442 (S442) and can be phosphorylated by PKA. This study examined the role of phosphorylating specific sites on the regulation of Mfn2 protein activity in vitro and in vivo. METHODS AND
RESULTS: We introduced two mutations at S442 in rat Mfn2, and investigated their effects using cultured rat VSMCs and the balloon injury model. Our results indicated that, in VSMCs, Mfn2 expression and mitochondrial morphology are affected by adenoviral-mediated overexpression of the two Mfn2 mutant proteins in the same way as the wild-type Mfn2 protein. Specifically, overexpression of the protein harboring the phospho-deficient mutation Mfn2-S442A (serine replaced by alanine at residue 442) increased the inhibitory effects of Mfn2 on proliferation of VSMCs in culture, and neointimal hyperplasia and restenosis in the rat carotid artery balloon injury model at days 14 after injury. On the other hand, the phospho-mimetic mutation Mfn2-S442D (serine replaced by aspartic acid at residue 442) led to loss of growth suppressor activity.
CONCLUSIONS: These results suggest that this specific PKA phosphorylation site plays a key role in Mfn2-mediated suppression of VSMC growth, which is independent of its effects on modulation of mitochondrial morphology. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20303493     DOI: 10.1016/j.atherosclerosis.2010.02.012

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  29 in total

Review 1.  Mitochondrial morphology and cardiovascular disease.

Authors:  Sang-Bing Ong; Derek J Hausenloy
Journal:  Cardiovasc Res       Date:  2010-07-14       Impact factor: 10.787

2.  Valsartan inhibits angiotensin II-induced proliferation of vascular smooth muscle cells via regulating the expression of mitofusin 2.

Authors:  Hua Liao; Junrong Gong; Wenjuan Zhang; Xiaomei Guo
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-01-27

Review 3.  Endoplasmic reticulum: ER stress regulates mitochondrial bioenergetics.

Authors:  Roberto Bravo; Tomás Gutierrez; Felipe Paredes; Damián Gatica; Andrea E Rodriguez; Zully Pedrozo; Mario Chiong; Valentina Parra; Andrew F G Quest; Beverly A Rothermel; Sergio Lavandero
Journal:  Int J Biochem Cell Biol       Date:  2011-11-02       Impact factor: 5.085

Review 4.  Mitochondrial dynamics in cardiovascular health and disease.

Authors:  Sang-Bing Ong; Andrew R Hall; Derek J Hausenloy
Journal:  Antioxid Redox Signal       Date:  2012-09-10       Impact factor: 8.401

Review 5.  Mitochondrial Morphofunction in Mammalian Cells.

Authors:  Elianne P Bulthuis; Merel J W Adjobo-Hermans; Peter H G M Willems; Werner J H Koopman
Journal:  Antioxid Redox Signal       Date:  2018-11-29       Impact factor: 8.401

6.  The phosphorylation status of Ser-637 in dynamin-related protein 1 (Drp1) does not determine Drp1 recruitment to mitochondria.

Authors:  Rong Yu; Tong Liu; Chenfei Ning; Fei Tan; Shao-Bo Jin; Urban Lendahl; Jian Zhao; Monica Nistér
Journal:  J Biol Chem       Date:  2019-09-18       Impact factor: 5.157

Review 7.  Redox control of vascular smooth muscle cell function and plasticity.

Authors:  Brittany G Durgin; Adam C Straub
Journal:  Lab Invest       Date:  2018-02-20       Impact factor: 5.662

8.  cAMP induces stromal interaction molecule 1 (STIM1) puncta but neither Orai1 protein clustering nor store-operated Ca2+ entry (SOCE) in islet cells.

Authors:  Geng Tian; Alexei V Tepikin; Anders Tengholm; Erik Gylfe
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

Review 9.  Mitochondrial redox status as a target for cardiovascular disease.

Authors:  James W Walters; Deborah Amos; Kristeena Ray; Nalini Santanam
Journal:  Curr Opin Pharmacol       Date:  2016-02-16       Impact factor: 5.547

10.  Mitofusin 2 deficiency leads to oxidative stress that contributes to insulin resistance in rat skeletal muscle cells.

Authors:  Qian Nie; Chao Wang; Guangyao Song; Huijuan Ma; Dexian Kong; Xuemei Zhang; Kexin Gan; Yong Tang
Journal:  Mol Biol Rep       Date:  2014-07-18       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.